Clinical Trials Browser

Phase 2/3 × Completed × Lymphoma, B-Cell × Clear all

NCT00147121 2016-09-22

Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)

Phase 2/3 Completed

Lymphoma, Follicular, Lymphoma, B-Cell